Delphiventures Security Rating

Delphi Ventures was founded over 25 years ago as one of the first venture capital firms to focus on investing in life sciences companies.We leverage our passion, expertise, deep experience and network to help advance new technologies and build market leading companies. Delphi has helped several drugs achieve market approval. Our firm has enabled dozens of companies to expand therapeutic access for patients who need less invasive procedures.With more than $1.1 billion in committed capital, Delphi Ventures has funded over 170 companies. More than 110 of our portfolio companies have either completed an initial public offering or have been acquired by a leading healthcare corporation.